Filing Details

Accession Number:
0001127602-19-031733
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-04 18:28:01
Reporting Period:
2019-11-01
Accepted Time:
2019-11-04 18:28:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726709 John Robert White Medtronic Plc
710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Evp & President Mitg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-11-01 9,643 $29.52 61,711 No 4 M Direct
Ordinary Shares Disposition 2019-11-01 3,762 $109.66 57,949 No 4 S Direct
Ordinary Shares Acquisiton 2019-11-01 37,209 $36.58 95,158 No 4 M Direct
Ordinary Shares Disposition 2019-11-01 28,428 $109.11 66,730 No 4 S Direct
Ordinary Shares Disposition 2019-11-01 14,662 $109.67 52,068 No 4 S Direct
Ordinary Shares Acquisiton 2019-11-01 5,313 $47.00 57,381 No 4 M Direct
Ordinary Shares Disposition 2019-11-01 3,349 $109.11 54,032 No 4 S Direct
Ordinary Shares Disposition 2019-11-01 1,964 $109.66 52,068 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-11-01 9,643 $0.00 9,643 $29.52
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-11-01 37,209 $0.00 37,209 $36.58
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-11-01 5,313 $0.00 5,313 $47.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-12-01 2021-11-30 No 4 M Direct
0 2013-12-03 2022-12-02 No 4 M Direct
25,442 2014-12-02 2023-12-01 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. This balance increased by 151 shares due to exempt transactions such as dividend reinvestment.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $109.98, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.44 to $109.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.45 to $110.18, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.46 to $109.43, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $110.01, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.